http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36212123

Outgoing Links

Predicate Object
contentType Journal Article
issn 2662-7671
issueIdentifier 1
pageRange 422-
publicationName BMC Complementary Medicine and Therapies
startingPage 422
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_415358f1dc7fa3df177726957a04c4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_090506ba7541af7c6c02694fe2b90d65
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_776ec35695b1ee5fe638577acdd62453
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_32940a0abcd950aa7cf46a88728a3deb
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d7f16bb77b0e97a30126443b38b80335
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3dcf084c89c7a72d4610021dab5c9c59
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_27f11856147f424f1f2b9f00ba8b27e9
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3970926b99ae3be12dc60fed684515c2
bibliographicCitation Han X, Liang L, He C, Ren Q, Su J, Cao L, Zheng J. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma. BMC Complement Med Ther. 2023 Nov 21;23(1):422. PMID: 37990309; PMCID: PMC10664478.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42d6f0286b8f6cfb5f3e861251c7c1fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f08b454497ae3bd7c68ffa56ef1a7647
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c27ab22be9dad883a050a93bfc71698
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddd2ac81b26957424ba4bcb11817f050
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fad101334c9cdad8e179082cd29833a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6762022265d31785ed0ef703ab7c760
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_726be82aaa325bcc23a70ce08039a52c
date 2023-11-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/s12906-023-04213-3
https://pubmed.ncbi.nlm.nih.gov/37990309
https://pubmed.ncbi.nlm.nih.gov/PMC10664478
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49207
https://portal.issn.org/resource/ISSN/2662-7671
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma
discusses http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0500817
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0543042
http://id.nlm.nih.gov/mesh/M0557577
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008175Q000235
http://id.nlm.nih.gov/mesh/D000077192Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D062105
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000091484
http://id.nlm.nih.gov/mesh/D019008
http://id.nlm.nih.gov/mesh/D066246Q000235
http://id.nlm.nih.gov/mesh/D019869
http://id.nlm.nih.gov/mesh/D047428Q000009
http://id.nlm.nih.gov/mesh/D066246Q000378

Showing number of triples: 1 to 48 of 48.